Pharmaceutical

Positive phase III results show Xofluza significantly reduces the transmission of influenza viruses

Data from the CENTERSTONE study shows single-dose Xofluza reduces transmission of influenza from an infected person to household membersThis is…

1 year ago

Addex Provisional 2024 Half-Year and Second Quarter Result increased from a Net loss to a Net Profit

Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, September 19, 2024 - Addex Therapeutics (SIX/NASDAQ: ADXN), a clinical-stage…

1 year ago

Cambrex Announces New Liquid-Phase Peptide Synthesis Manufacturing Technology

EAST RUTHERFORD, N.J., Sept. 19, 2024 /PRNewswire/ -- Cambrex, a leading global contract development and manufacturing organization (CDMO), today announced…

1 year ago

TFS HealthScience Unveils Mission to Empower Partners and Enrich Lives Worldwide

New messaging reflects TFS's commitment to patient-centered clinical research and global partnerships LUND, Sweden, Sept. 19, 2024 /PRNewswire/ -- TFS HealthScience…

1 year ago

Angle PLC Announces Agreement with Recursion Pharmaceuticals

New pharma agreement for Parsortix CTC analysisGUILDFORD, SURREY / ACCESSWIRE / September 19, 2024 / ANGLE plc (AIM:AGL)(OTCQX:ANPCY), a world-leading…

1 year ago

GE HealthCare announces cash dividend for third quarter of 2024

CHICAGO--(BUSINESS WIRE)--The Board of Directors of GE HealthCare Technologies Inc. (Nasdaq: GEHC) today declared a cash dividend of $0.03 per…

1 year ago

Nanocoatings Market Surges to USD 20.4 Billion by 2030, Propelled by 6.9% CAGR – Verified Market Reports®

The Nanocoatings market is driven by increasing demand across industries like automotive, electronics, and healthcare, where the coatings' enhanced durability,…

1 year ago

Live Cell Imaging Market Surges to USD 4.42 Billion by 2030, Propelled by 7.52% CAGR – Verified Market Reports®

The live cell imaging market is driven by advancements in cell biology research, increasing demand for high-content screening, and the…

1 year ago

OM1 Earns Frost & Sullivan’s 2024 North American New Product Innovation Award for Transforming Real-world Evidence Analytics Solutions Industry with Its Pioneering AI-powered Platforms

OM1's innovative solutions, such as Orion, Lyra, and Polaris, are revolutionizing patient journey analysis and clinical research through deep AI…

1 year ago